Table 1.
Baseline characteristics
| Parameter | Number (%), mean ± SDa or median with IQRb |
|---|---|
| Number of patients | 176 (100%) |
| Age (years) | 51.8 ± 14.1 |
| Sex | |
| Male | 111 (63.1%) |
| Female | 65 (36.9%) |
| Type of kidney donor | |
| Living | 146 (83.0%) |
| Deceased | 30 (17.0%) |
| Type of dialysis | |
| Hemodialysis | 73 (41.5%) |
| Peritoneal dialysis | 29 (16.5%) |
| Hemodialysis and peritoneal dialysis | 2 (1.1%) |
| Pre-emptive | 72 (40.9%) |
| Duration dialysis (months) | 16.7 ± 21.6 |
| BMIc (kg/m2) | 26.0 ± 4.3 |
| Hypertension | 98 (55.7%) |
| Comorbiditiesd | 3.7 ± 1.6 |
| Retransplantation | 25 (14.2%) |
| Paired exchange | 14 (8%) |
| Length of stay (days) | 10.1 ± 5.6 |
| First warm ischemia time (minutes) | |
| Living | 3 (3–4) |
| Deceased | 9 (0–16) |
| Cold ischemia time (minutes) | 162 (150–225) |
| Second warm ischemia time (minutes) | 39.0 ± 11.1 |
| Delayed graft function | 19 (10.8%) |
| Acute rejection | 12 (6.8%) |
| Intensive care unit admission | 11 (6.3%) |
| Readmission within 30 days of KTe | 20 (11.4%) |
| Time between KT and follow-up (months) | 22.8 ± 8.3 |
| Readmission during follow-up | 82 (46.6%) |
| Redo surgery during follow-up | 44 (25.0%) |
aStandard deviation
bInterquartile range
cBody mass index
dAccording to the Charlson Comorbidity Index, a weighted index which predicts the 1-year mortality by measuring the burden of comorbidities (range from 0 to 19)
eKidney transplantation